Firstly, exposure to and progression after first-line chemotherapy may select and/or promote an angiogenic phenotype—that is, tumour biology may be altered by chemotherapy such that tumours are more sensitive to subsequent targeting of the VEGF pathway. Here, VEGFA is linked to neoplasm.